These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8950475)

  • 1. FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease.
    Lynch DH; Campbell KA; Miller RE; Badley AD; Paya CV
    Behring Inst Mitt; 1996 Oct; (97):175-84. PubMed ID: 8950475
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of apoptosis in mature T cells by tumour necrosis factor.
    Zheng L; Fisher G; Miller RE; Peschon J; Lynch DH; Lenardo MJ
    Nature; 1995 Sep; 377(6547):348-51. PubMed ID: 7566090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TNF family (TNF alpha, beta, FasL, CD40L)].
    Manago S; Yonehara S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():202-6. PubMed ID: 15861657
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
    Walczak H; Krammer PH
    Exp Cell Res; 2000 Apr; 256(1):58-66. PubMed ID: 10739652
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways.
    Mountz JD; Zhou T; Su X; Cheng J; Pierson M; Bluethmann H; Edwards CK
    Behring Inst Mitt; 1996 Oct; (97):200-19. PubMed ID: 8950477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF; Cook WJ; Green WR
    Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis.
    Heumann D; Le Roy D; Zanetti G; Eugster HP; Ryffel B; Hahne M; Tschopp J; Glauser MP
    J Inflamm; 1995-1996; 47(4):173-9. PubMed ID: 9144074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death ligand-mediated apoptosis in HIV infection.
    Miura Y; Koyanagi Y
    Rev Med Virol; 2005; 15(3):169-78. PubMed ID: 15765545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new apoptotic pathway for the complement factor B-derived fragment Bb.
    Uwai M; Terui Y; Mishima Y; Tomizuka H; Ikeda M; Itoh T; Mori M; Ueda M; Inoue R; Yamada M; Hayasawa H; Horiuchi T; Niho Y; Matsumoto M; Ishizaka Y; Ikeda K; Ozawa K; Hatake K
    J Cell Physiol; 2000 Nov; 185(2):280-92. PubMed ID: 11025450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha.
    Gorak-Stolinska P; Truman JP; Kemeny DM; Noble A
    J Leukoc Biol; 2001 Nov; 70(5):756-66. PubMed ID: 11698496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of Fas/FasL in tuberculosis].
    Liu JH; Wang YN; Zhang CL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):783-6. PubMed ID: 15634397
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A; Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membrane protein Fas/FasL system in viral infections].
    Ma BJ; Hang CS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):94-7. PubMed ID: 12526314
    [No Abstract]   [Full Text] [Related]  

  • 18. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60.
    Weiss T; Grell M; Siemienski K; Mühlenbeck F; Dürkop H; Pfizenmaier K; Scheurich P; Wajant H
    J Immunol; 1998 Sep; 161(6):3136-42. PubMed ID: 9743381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.